Global Molybdenum-99 and Technetium-99m Market Analysis and Forecast 2026-2032

Molybdenum-99 (Mo-99) is a short-lived medical radioisotope that serves as the parent nuclide for generator production of technetium-99m. It decays by beta emission to Tc-99m with a physical half-life of about 66 hours, and its industrial significance is defined less by direct clinical use than by its role in high-reliability supply of Tc-99m through Mo-99 Tc-99m generators deployed at nuclear pharmacies and hospitals. In practice, Mo-99 is produced at high specific activity primarily as a uranium fission product (the route that enables compact generator loading), then chemically processed and immobilized in generator media so that Tc-99m can be repeatedly “milked” on demand.

Technetium-99m (Tc-99m) is the metastable nuclear isomer of technetium-99 and the dominant radionuclide used for routine diagnostic nuclear medicine imaging. It has a physical half-life of about 6 hours and decays mainly by isomeric transition, emitting a characteristic ~140 keV gamma photon that is well matched to gamma-camera and SPECT detector physics while keeping patient radiation burden practical for large-volume diagnostics. Clinically, Tc-99m is most commonly obtained as sterile sodium pertechnetate (TcO₄⁻) eluate from a Mo-99 generator and then converted into a broad range of Tc-99m radiopharmaceuticals via reduction and coordination chemistry (kit-based labeling), enabling targeted imaging across organs and disease processes with standardized workflow and reproducible image quality.

Technetium-99m is predominantly sourced from molybdenum-99 technetium-99m generators, where parent molybdenum-99 is retained in the generator and technetium-99m is periodically recovered via elution for radiopharmaceutical preparation. Its gamma emission profile makes it the most practical workhorse radionuclide for single-photon emission computed tomography, and this installed base remains broad, with SPECT systems deployed across more than 140 countries and roughly 27,000 units in operation; in the United States alone, technetium-99m supports over 40,000 procedures per day. The market’s defining structural feature is that demand is clinically resilient while supply is operationally fragile, because production depends on a small set of aging research reactors, time-critical processing, and international logistics that can be disrupted by outages, maintenance cycles, or transport constraints.

In APO Research’s 2026 update, global molybdenum-99 and technetium-99m production value reached about USD 660.9 million in 2025 and is forecast to rise to USD 687.2 million in 2026; by 2032, production value is projected to approach USD 900.1 million, corresponding to a 2026–2032 compound annual growth rate of 4.6%. In parallel, global nameplate molybdenum-99 supply capacity is assessed at about 1,340.3 kCi in 2025 and is expected to reach 1,386.5 kCi in 2026, rising to around 1,699.4 kCi by 2032, implying a 2026–2032 compound annual growth rate of 3.5% (kCi refers to thousand 6-day curies of molybdenum-99 per year). Realized production is estimated at about 1,254.4 kCi in 2025 and about 1,299.8 kCi in 2026, increasing to roughly 1,609.4 kCi by 2032, which equates to a 2026–2032 compound annual growth rate of 3.6%. Pre-2025 historical volatility remains relevant primarily as a concentration-risk reference point rather than a demand story, with prior shortages demonstrating that marginal capacity is not equivalent to reliable deliverable supply.

Regionally, Europe continues to represent the core of bulk molybdenum-99 value creation, supported by established irradiation and processing infrastructure. Belgium is projected at USD 233.1 million in 2025 and USD 243.7 million in 2026, with 2032 projected at about USD 333.9 million, implying a 2026–2032 compound annual growth rate of 5.4%; the Netherlands is projected at USD 164.9 million in 2025 and USD 173.0 million in 2026, rising to roughly USD 232.5 million by 2032, implying a 2026–2032 compound annual growth rate of 5.1%. South Africa remains a material non-European pillar in the supply map, projected at USD 82.1 million in 2025 and USD 85.2 million in 2026, reaching around USD 111.6 million by 2032, consistent with a mid-single-digit growth profile. These trajectories reflect not only underlying procedure growth but also the strategic premium placed on continuity of supply and redundancy, particularly when international transport capacity tightens.

On the supply side, a small number of reactors and operators still anchor the effective deliverable capacity: BR-2 in Belgium and HFR in the Netherlands remain the two largest accessible contributors by weekly output ratings, complemented by OPAL in Australia, SAFARI-1 in South Africa, and additional capacity such as NIIAR in Russia. Rated weekly capacities are commonly referenced at approximately 7,800 6-day Ci per week for BR-2 and 6,200 6-day Ci per week for HFR, versus around 3,500 6-day Ci per week for OPAL and around 3,000 6-day Ci per week for SAFARI-1, with substantially smaller weekly capacity disclosed for NIIAR. Structurally, the market continues to shift toward low-enriched uranium targets and away from highly enriched uranium, driven by non-proliferation policy and waste-management considerations; by type, low-enriched uranium-based production value is estimated at USD 632.9 million in 2025 and USD 660.1 million in 2026, rising to roughly USD 878.2 million by 2032, while highly enriched uranium-based value declines from USD 28.0 million in 2025 to USD 27.2 million in 2026 and to about USD 21.9 million by 2032. By application, medical imaging dominates the value pool, estimated at USD 547.8 million in 2025 and USD 568.6 million in 2026, reaching roughly USD 736.7 million by 2032, with the remainder attributable to other end uses and isotope applications.

This report presents an overview of global market for Molybdenum-99 and Technetium-99m, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Molybdenum-99 and Technetium-99m, also provides the consumption of main regions and countries. Of the upcoming market potential for Molybdenum-99 and Technetium-99m, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Molybdenum-99 and Technetium-99m sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Molybdenum-99 and Technetium-99m market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Molybdenum-99 and Technetium-99m sales, projected growth trends, production technology, application and end-user industry.

IRE

NRG

ANSTO

NTP

Rosatom

Produced by HEU

Produced by LEU

Medical Imaging

Others

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Molybdenum-99 and Technetium-99m market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Molybdenum-99 and Technetium-99m and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Molybdenum-99 and Technetium-99m.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Molybdenum-99 and Technetium-99m production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Molybdenum-99 and Technetium-99m in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Molybdenum-99 and Technetium-99m manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Molybdenum-99 and Technetium-99m sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.